The five-year National Institutes of Health grant will enable Charles Downs, PhD, to study whether the non-pharmacological supplement curcumin can prevent lung injury.Continue reading
Author Archive: AZBio
INSYS Therapeutics Provides an Update on Its Ongoing Transformation
PHOENIX, June 18, 2018 (GLOBE NEWSWIRE) — INSYS Therapeutics, Inc. (NASDAQ:INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today reiterated its ongoing efforts to fundamentally transform the company. Below is a synopsis of these ongoing efforts.Continue reading
AMAG Announces Plans to Sell CBR® to GI Partners for $530M
AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) announced, on June 15, 2018, that it has entered into a definitive agreement to divest Cord Blood Registry (CBR®) to GI Partners, a private equity investment firm, for $530 million in an all cash sale. The parties expect to close the transaction in the third quarter of 2018.
GI Partners will also simultaneously acquire California Cryobank (CCB), the world’s premier donor sperm and egg bank in a combined transaction.
Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Intramuscular Injection
Allergy sufferers who experience anaphylaxis—an acute, life-threatening allergic reaction requiring urgent treatment—may soon have a new delivery option for receiving a timely dose of epinephrine to avoid a potentially fatal outcome.
Continue reading
Photometrics® and arivis Form New Partnership for Big Data Image Acquisition and Handling Photometrics Scientific CMOS, EMCCD and CCD Cameras
U.S.-based camera company Photometrics and German-based software company arivis, have teamed up to provide imaging and big data handling solutions to researchers to streamline their science. This partnership provides new imaging technology and software to produce more detailed data while handling those data efficiently. Photometrics is headquartered in Tucson, Arizona. Arivis, Inc., the U.S. subsidiary of arivis, is based in Phoenix, Arizona.Continue reading
Startup Licenses UA-invented Disruptive Biopsy Device
Company targets accelerated diagnosis and treatment of cancer by providing optimal tissue samples for effective personalized medicineContinue reading
SenesTech Reaches a Distribution Agreement with Bug Off Pest Control Center of New York City for ContraPest®
SenesTech, Inc. (NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, today announced a distribution agreement with Bug Off Pest Control Center (“Bug Off”) for ContraPest®. In addition to distribution, Bug Off will be marketing and selling ContraPest throughout its network, and providing ongoing training to pest management professionals (PMPs) in the Greater New York area.Continue reading
UA Receives $1.1M for Study of Genetic Risk Factors for Type 2 Diabetes and Heart Disease
Some people who take statins to lower cholesterol have a slightly higher risk of developing type-2 diabetes. Genetic epidemiologist Yann Klimentidis, PhD, at the UA Mel and Enid Zuckerman College of Public Health received a $1.1 million grant from the National Institutes of Health to study the connection between type-2 diabetes and cardiovascular disease.Continue reading